A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
The presence of P+PBac{XP5.WH5}BSC810 was verified using the PCR methods and primers described in FBrf0175003.
The breakpoints of Df(2L)BSC810 predicted from the Release 5 genomic coordinates of the progenitor PBac{WH}nompCf00642 and P{XP}d04336 insertion sites are 2L:5352777 ;5547113 and the cytological breakpoints predicted from these coordinates are 25D6;25E6.